Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000;1(1):19-21.
doi: 10.1186/cvm-1-1-019.

Noninferiority trials

Steven M Snapinn  1
Affiliations

Noninferiority trials

Steven M Snapinn. Curr Control Trials Cardiovasc Med. 2000.

Abstract

Noninferiority trials are intended to show that the effect of a new treatment is not worse than that of an active control by more than a specified margin. These trials have a number of inherent weaknesses that superiority trials do not: no internal demonstration of assay sensitivity, no single conservative analysis approach, lack of protection from bias by blinding, and difficulty in specifying the noninferiority margin. Noninferiority trials may sometimes be necessary when a placebo group can not be ethically included, but it should be recognized that the results of such trials are not as credible as those from a superiority trial.

PubMed Disclaimer

References

    1. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 1999;354:716–722. doi: 10.1016/S0140-6736(99)07403-6. - DOI - PubMed
    1. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337:1118–1123. doi: 10.1056/NEJM199710163371603. - DOI - PubMed
    1. The Continuous Infusion Versus Double-Bolus Administration of Alteplase (COBALT) Investigators A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction. . N Engl J Med. 1997;337:1124–1130. doi: 10.1056/NEJM199710163371604. - DOI - PubMed
    1. Ware JH, Antman EM. Equivalence trials. N Engl J Med . 1997;337:1159–1161. doi: 10.1056/NEJM199710163371610. - DOI - PubMed
    1. Garbe E, Röhmel J, Gundert-Remy U. Clinical and statistical issues in therapeutic equivalence trials. Eur J Clin Pharmacol . 1993;45:1–7. - PubMed

LinkOut - more resources